Form 4 for STE Steris
Accepted 2021-10-05 00:00:00 ET · period of report 2021-10-01 · accession 0001209191-21-059528 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-05 | 2021-10-01 | STE | Fraser Mary Clare | VP, Chief HRO | A - Grant | $0.00 | +692 | 5,458 | +15% | $0 |
| D | 2021-10-05 | 2021-10-01 | STE | Fraser Mary Clare | VP, Chief HRO | A - Grant | $0.00 | +3,784 | 3,784 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2021-10-01 | A | A | 692 | $0.00 | 5,458 | D | — | — | (F1) All 692 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse on October 1, 2025. (F2) 4,901 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 791 on June 1, 2022; 791 on June 1, 2023; 791 on June 1, 2024; 1,836 on June 2, 2025 and 692 on October 1, 2025. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2021-10-01 | A | A | 3,784 | $0.00 | 3,784 | D | $228.36 · — to 2031-10-01 | 3,784 Ordinary Shares | (F3) This option becomes exercisable as follows: 946 on October 3, 2022; 946 on October 2, 2023; 946 on October 1, 2024 and 946 on October 1, 2025. |